I am professor and chair of the Department of Radiation Oncology at The Ohio State University, where I also hold the Max Morehouse Chair of Cancer Research and direct the Brain Tumor Program. In addition, I am in the Translational Therapeutics Program at Ohio State’s Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute. I was named to the Castle Connolly list of “America's Top Doctors” from 2012-2018.
Nationally, I chair the Board of Directors of the International Society of Neuro-Radiation Biology, chair the Radiation Therapy and Oncology Group (RTOG) Brain Tumor Translational Research Subcommittee, and co-chair the RTOG Brain Tumor Committee. I also am on the Board of Directors of the Ohio Neuro-Oncology Consortium.
My leadership roles in these organizations have led to translational research studies that define the current standard of care for patients with central nervous system tumors. My approach is to personalize cancer care by investigating strategies that are most effective to individual patients through genetic and molecular profiling instead of using the “one glove fits all” approach that is more commonly used in cancer care. In Ohio State’s cancer program, we appreciate that every patient is unique and requires targeted strategies for optimal personalized care.
Additionally, I’ve published more than 120 articles in leading scientific and medical journals, including the New England Journal of Medicine, Journal of the American Medical Association, Cancer Cell and Journal of Clinical Oncology. I have delivered numerous distinguished lectureships in the United States, Asia and Europe on cutting-edge therapies for cancer patients and have received more than two dozen national and international awards for outstanding clinical care and landmark research accomplishments.